Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

DRIO Mar 2022 20.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.3500-0.1500 (-10.00%)
As of 01:05PM EST. Market open.
Advertisement
Full screen
Previous Close1.5000
Open1.3500
Bid0.6000
Ask1.6000
Strike20.00
Expire Date2022-03-18
Day's Range1.3500 - 1.3500
Contract RangeN/A
Volume1
Open Interest91
  • PR Newswire

    DarioHealth Announces Two New Contracts within the Employer and Provider Markets

    DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. The new clients include a regional employer contract for behavioral health, and a strategic partnership in the provider market that will allow Dario solutions to be sold through a network of practices across the United States. The two new contracts mark a key milestone for Dario, b

  • PR Newswire

    DarioHealth Announces Two New Employer Contracts

    DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers to provide its highly personalized digital therapeutic beginning in the first quarter of 2022.

  • Zacks Small Cap Research

    DRIO: 47 New Contracts Year to Date

    By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Third Quarter 2021 Financial and Operational Results On November 15, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced its third quarter 2021 operational and financial results and filed its Form 10-Q . Dario hosted a conference call the following morning to discuss results in further detail. Dario’s growth is accelerating with

Advertisement
Advertisement